Eder Therapeutics and XCubeBio Partner to Establish Joint NewCo for Global Development and Future Market Entry Activities
Eder Therapeutics, a Canadian biopharmaceutical company focused on rare genetic disorders and XCubeBio AG, a biotechnology platform company focused on accelerating successful international market entry for innovative therapeutics, today announced their intention to...



